Cargando…

Correction to: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism

Detalles Bibliográficos
Autores principales:	Zhang, Zhen, Li, Jianjun, Ou, Yang, Yang, Guang, Deng, Kaiyuan, Wang, Qiong, Wang, Zhaoyang, Wang, Wenhao, Zhang, Quansheng, Wang, Hang, Sun, Wei, Sun, Peiqing, Yang, Shuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305231/ https://www.ncbi.nlm.nih.gov/pubmed/34145216 http://dx.doi.org/10.1038/s41392-020-00212-9

Ejemplares similares

CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism
por: Zhang, Zhen, et al.
Publicado: (2020)

Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1
por: Jiang, Huimin, et al.
Publicado: (2020)

USP14 regulates cell cycle progression through deubiquitinating CDK1 in breast cancer: USP14 deubiquitinates CDK1 in breast cancer
por: Liu, Yuhan, et al.
Publicado: (2022)

USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer
por: Li, Jianjun, et al.
Publicado: (2023)

ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3
por: Zhou, Chen, et al.
Publicado: (2017)

Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer
por: Jiang, Huimin, et al.
Publicado: (2022)

Deubiquitination and stabilization of PTEN by USP13
por: Zhang, Jinsong, et al.
Publicado: (2013)

ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
por: Zhang, Xiang, et al.
Publicado: (2018)

ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
por: Zhang, Jianbo, et al.
Publicado: (2017)

Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1
por: Li, Jianjun, et al.
Publicado: (2022)

USP10 deubiquitinates Tau, mediating its aggregation
por: Wei, Zhen, et al.
Publicado: (2022)

USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation
por: Zhang, Deng Yong, et al.
Publicado: (2023)

USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1
por: Chen, Jin, et al.
Publicado: (2023)

USP13 negatively regulates antiviral responses by deubiquitinating STING
por: Sun, He, et al.
Publicado: (2017)

Author Correction: USP4 positively regulates RLR-induced NF-κB activation by targeting TRAF6 for K48-linked deubiquitination and inhibits enterovirus 71 replication
por: Xu, Chao, et al.
Publicado: (2023)

The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review
por: Yang, Guang-Fei, et al.
Publicado: (2021)

Usp10 Modulates the Hippo Pathway by Deubiquitinating and Stabilizing the Transcriptional Coactivator Yorkie
por: Gao, Yang, et al.
Publicado: (2019)

Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
por: Sun, Xiaohan, et al.
Publicado: (2019)

Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth
por: Zhang, Lei, et al.
Publicado: (2015)

Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11
por: Vlasschaert, Caitlyn, et al.
Publicado: (2015)

USP1 Maintains the Survival of Liver Circulating Tumor Cells by Deubiquitinating and Stabilizing TBLR1
por: Li, Yuancheng, et al.
Publicado: (2020)

USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer
por: Pan, Beiqing, et al.
Publicado: (2019)

USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM
por: Wu, Chenming, et al.
Publicado: (2021)

USP21 modulates Goosecoid function through deubiquitination
por: Liu, Fuwei, et al.
Publicado: (2019)

USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA
por: Zhang, Hong-Yan, et al.
Publicado: (2020)

Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity
por: Gersch, Malte, et al.
Publicado: (2019)

Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth
por: Yang, Bo, et al.
Publicado: (2016)

ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer
por: Liu, Lingjia, et al.
Publicado: (2016)

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022)

Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency
por: Ma, Yu-Shui, et al.
Publicado: (2020)

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
por: Ge, Jianchao, et al.
Publicado: (2021)

A quaternary tetramer assembly inhibits the deubiquitinating activity of USP25
por: Liu, Bing, et al.
Publicado: (2018)

Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein
por: Yuan, Tao, et al.
Publicado: (2019)

USP7 Promotes deubiquitination and stabilization of MyD88 to enhance immune responses
por: Zhang, Na, et al.
Publicado: (2022)

Deubiquitinating Enzyme USP8 Is Essential for Skeletogenesis by Regulating Wnt Signaling
por: Chaugule, Sachin, et al.
Publicado: (2021)

The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ
por: Li, Jin, et al.
Publicado: (2022)

Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling
por: Jung, H, et al.
Publicado: (2013)

Deubiquitination in prostate cancer progression: role of USP22
por: Nag, Nivedita, et al.
Publicado: (2020)

USP17 Suppresses Tumorigenesis and Tumor Growth through Deubiquitinating AEP
por: Chen, Xi, et al.
Publicado: (2019)

USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
por: Zeng, Kai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j435808592qvumtbd5ia1prsdc